123). It can be notable that GLS2 is tumorigenic in breast cancer124, and its expression could compensate for lack of Gls in MYC-induced mouse liver tumours40. This means that GLS2 could confer resistance to GLS1-precise inhibitors, like the allosteric inhibitor BPTES or CB-839, and this resistance can be hypothetically averted https://shanewdhko.blogsvirals.com/28633782/not-known-details-about-fgf2-protein